Division of Immunology and the Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
Division of Immunology and the Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass.
J Allergy Clin Immunol. 2014 Aug;134(2):262-8. doi: 10.1016/j.jaci.2013.08.021. Epub 2013 Oct 5.
There are more than 180 different genetic causes of primary immunodeficiencies identified to date. Approaches for identifying causative mutations can be broadly classified into 3 strategies: (1) educated guesses based on known signaling pathways essential for immune cell development and function, (2) similarity of clinical phenotypes to mouse models, and (3) unbiased genetic approaches. Next-generation DNA sequencing permits efficient sequencing of whole genomes or exomes but also requires strategies for filtering vast amounts of data. Recent studies have identified ways to solve difficult cases, such as diseases with autosomal dominant inheritance, incomplete penetrance, or mutations in noncoding regions. This review focuses on recently identified primary immunodeficiencies to illustrate the strategies, technologies, and potential pitfalls in finding novel causes of these diseases.
迄今为止,已确定超过 180 种原发性免疫缺陷的遗传原因。鉴定致病突变的方法可大致分为 3 种策略:(1)基于对免疫细胞发育和功能至关重要的已知信号通路的有根据的猜测;(2)临床表型与小鼠模型的相似性;(3)无偏倚的遗传方法。下一代 DNA 测序允许对整个基因组或外显子组进行高效测序,但也需要策略来过滤大量数据。最近的研究已经确定了如何解决困难病例的方法,例如具有常染色体显性遗传、不完全外显率或非编码区域突变的疾病。本综述重点介绍了最近发现的原发性免疫缺陷,以说明发现这些疾病新病因的策略、技术和潜在陷阱。